(VIANEWS) – CTT CORREIOS PORT (CTT.LS), MOWI (MOWI.OL), MEDISTIM (MEDI.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. CTT CORREIOS PORT (CTT.LS)
327.5% sales growth and 22.58% return on equity
CTT – Correios De Portugal, S.A., together with its subsidiaries, provides postal and financial services worldwide. It operates through Mail, Express & Parcels, Financial Services & Retail, and Bank segments. The company offers courier and urgent mail transport services; postal financial services; and banking services. It also engages in the business of payments related to collection of invoices and fines. In addition, the company enables the payment of various services and utilities through a network of approximately 5,000 agents covering business outlets as stationery stores, tobacco shops, kiosks, and supermarkets. It operates a retail network of 566 post offices; 1,808 postal agencies; 223 postal delivery offices; 4,576 postal delivery routes; and a fleet of 3,925 vehicles. The company was formerly known as Correio Publico. CTT – Correios De Portugal, S.A. was founded in 1520 and is headquartered in Lisbon, Portugal.
Earnings Per Share
As for profitability, CTT CORREIOS PORT has a trailing twelve months EPS of €0.25.
PE Ratio
CTT CORREIOS PORT has a trailing twelve months price to earnings ratio of 13.52. Meaning, the purchaser of the share is investing €13.52 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.58%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.1%, now sitting on 893.88M for the twelve trailing months.
Volume
Today’s last reported volume for CTT CORREIOS PORT is 53077 which is 80.45% below its average volume of 271493.
More news about CTT CORREIOS PORT.
2. MOWI (MOWI.OL)
19% sales growth and 24.25% return on equity
Mowi ASA, a seafood company, produces and supplies farmed salmon products worldwide. It operates through three segments: Feed, Farming, and Sales and Marketing. The company is involved in the salmon feed production, salmon farming and primary processing, and seafood secondary processing activities. It offers whole gutted fish, including Label Rouge and organic salmon; and white fish and other seafood products, as well as fillets, steaks, cutlets, portions, loins, kebabs, and steak combos. The company also provides value added products, such as breaded, pre-fried, dusted, marinated, grilled, battered, topped, filled with sauce, delicatessen, fresh fish ready meal, and smoked fish products. It offers its products under the Mowi, Mowi Salmon, Donegal Silver, Admiral's, Pieters, Laschinger, Kritsen, Ducktrap River, Harbour Salmon Co., Rebel Fish, Supreme Salmon, Olav's, Northern Harvest, and Mowi Nutrition brand names. The company was formerly known as Marine Harvest ASA and changed its name to Mowi ASA in December 2018. Mowi ASA was founded in 1964 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, MOWI has a trailing twelve months EPS of kr19.46.
PE Ratio
MOWI has a trailing twelve months price to earnings ratio of 10.3. Meaning, the purchaser of the share is investing kr10.3 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.25%.
Volume
Today’s last reported volume for MOWI is 1418090 which is 45.03% above its average volume of 977772.
More news about MOWI.
3. MEDISTIM (MEDI.OL)
16.7% sales growth and 31.89% return on equity
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.7.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 40.75. Meaning, the purchaser of the share is investing kr40.75 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.89%.
More news about MEDISTIM.
4. ALTRI SGPS (ALTR.LS)
16% sales growth and 24.22% return on equity
Altri, SGPS, S.A. produces and sells cellulosic fibers and energy in Portugal and internationally. The company produces pulp products for various application including production of paper, tissue, and printing and writing papers; and dissolving pulp for use of textile production. It is also involved timber commercialization; forest management; production of forest-based renewable energy, such as industrial cogeneration from black liquor and biomass; real estate activities; and production of plants in nurseries, as well as the provision of services related with forests and landscapes. The company was incorporated in 2005 and is headquartered in Porto, Portugal.
Earnings Per Share
As for profitability, ALTRI SGPS has a trailing twelve months EPS of €0.74.
PE Ratio
ALTRI SGPS has a trailing twelve months price to earnings ratio of 5.81. Meaning, the purchaser of the share is investing €5.81 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.22%.
Volume
Today’s last reported volume for ALTRI SGPS is 979993 which is 12.17% below its average volume of 1115790.
Moving Average
ALTRI SGPS’s worth is way under its 50-day moving average of €4.82 and way below its 200-day moving average of €5.48.
Sales Growth
ALTRI SGPS’s sales growth is 73.9% for the present quarter and 16% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ALTRI SGPS’s EBITDA is 15.43.
More news about ALTRI SGPS.
5. WEBSTEP (WSTEP.OL)
11.6% sales growth and 11.66% return on equity
Webstep ASA, together with its subsidiaries, provides information technology (IT) consultancy services to public and private businesses in Norway and Sweden. The company offers digitalization, cloud migration and integration, Internet of Things, machine learning, IT security, robotics, and analytics. Its services include consulting, digitalization, .Net, Java, open source, full stack, front and back end, user experience, integration, mobility, cloud apps, machine learning, business intelligence, big data, data warehousing, virtual robotics, Devops, application service management, and data science services; and cloud computing, cloud services, integration, sensor technology, product and service development, Beacons, enterprise user experience, web analysis, design team, Amazon Web, Azure, prediction, AI, mobility predictive modelling, predictive modelling, hackathon, business analysis, and search engine optimization services. The company serves banking, finance and insurance, public administration, agriculture and food production, IT and telecommunication, commerce, and transportation industries. The company was founded in 2000 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, WEBSTEP has a trailing twelve months EPS of kr1.41.
PE Ratio
WEBSTEP has a trailing twelve months price to earnings ratio of 21.7. Meaning, the purchaser of the share is investing kr21.7 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.66%.
Volume
Today’s last reported volume for WEBSTEP is 600 which is 96.67% below its average volume of 18034.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 860.81M for the twelve trailing months.
More news about WEBSTEP.
6. ORKLA (ORK.OL)
8% sales growth and 12.65% return on equity
Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery channels, as well as food service, convenience stores, and petrol stations. It also provides confectionery, biscuit, and snack products; and develops bran and crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic and wool garments for men, women, and children; and professional cleaning products. Further, it operates Gymgrossisten, Proteinfabrikken, Bodystore, and Fitnessmarket e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, NATURLI', Abba, Beauvais, Den Gamle Fabrik, Spilva, and Vitana brands; confectionery and snacks under the KiMs, Nidar, Stratos, Sætre, Göteborgs Kex, OLW, Panda, Laima, Selga, Taffel, Kalev, and Nói Síríus brands; health and sports nutrition under e Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under the Odense, Mors Hjemmebakte, KronJäst, Bakkedal, and NATURLI brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company was founded in 1918 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, ORKLA has a trailing twelve months EPS of kr5.23.
PE Ratio
ORKLA has a trailing twelve months price to earnings ratio of 15.5. Meaning, the purchaser of the share is investing kr15.5 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.65%.
Yearly Top and Bottom Value
ORKLA’s stock is valued at kr81.06 at 12:20 EST, under its 52-week high of kr85.20 and way above its 52-week low of kr67.06.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 14, 2023, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 3.68%.
More news about ORKLA.
